A Survey of Less Invasive Surfactant Administration Usage in India.
Bronchopulmonary dysplasia
LISA
Surfactant
Survey
Journal
Indian journal of pediatrics
ISSN: 0973-7693
Titre abrégé: Indian J Pediatr
Pays: India
ID NLM: 0417442
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
29
05
2022
accepted:
30
09
2022
pubmed:
15
11
2022
medline:
19
1
2023
entrez:
14
11
2022
Statut:
ppublish
Résumé
Less invasive surfactant administration (LISA) has evolved as an alternative method for surfactant administration. An anonymous web-based survey of 22 questions was designed and sent to 127 neonatologists in India. Seventy-seven (61%) responses were returned from 22 states across India. Among 77 participants, 53 (68.8%) were using LISA, and amongst them, 19 (35.8%) were using LISA as the preferred method. Twenty-one (39.6%) LISA-using respondents learned the technique of LISA by watching online videos, whereas 20 (37.7%) acquired this skill during in-house training sessions. Nineteen (35.8%) centers were not using any premedication before performing LISA. Twenty (37.7%) participants notified regurgitation of surfactant needing a repeat dose as the most common problem encountered while performing LISA. The most common reason for not using LISA was lack of training (n = 20, 83.33%). Though LISA is a promising method of surfactant administration, not many centers prefer LISA in India due to the absence of uniform standardized training.
Identifiants
pubmed: 36376547
doi: 10.1007/s12098-022-04390-y
pii: 10.1007/s12098-022-04390-y
doi:
Substances chimiques
Surface-Active Agents
0
Pulmonary Surfactants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
181-183Informations de copyright
© 2022. Crown.
Références
Isayama T. Minimally invasive surfactant therapy to prevent bronchopulmonary dysplasia in extremely preterm infants. JAMA. 2021;326:2475–6.
doi: 10.1001/jama.2021.21667
Abdel-Latif ME, Davis PG, Wheeler KI, De Paoli AG, Dargaville PA. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2021;5:CD011672.
Dargaville PA, Kamlin COF, Orsini F, et al; OPTIMIST-A Trial Investigators. Effect of minimally invasive surfactant therapy vs sham treatment on death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: The OPTIMIST-A Randomized Clinical Trial. JAMA. 2021;326:2478–87.
Fernandez C, Boix H, Camba F, Comuñas JJ, Castillo F. Less invasive surfactant administration in spain: a survey regarding its practice, the target population, and premedication use. Am J Perinatol. 2020;37:277–80.
doi: 10.1055/s-0039-1678534
Heiring C, Jonsson B, Andersson S, Björklund LJ. Survey shows large differences between the Nordic countries in the use of less invasive surfactant administration. Acta Paediatr. 2017;106:382–6.
doi: 10.1111/apa.13694
Jeffreys E, Hunt K, Dassios T, Greenough A. UK survey of less invasive surfactant administration. Arch Dis Child Fetal Neonatal Ed. 2019;104:F567.
doi: 10.1136/archdischild-2018-316466
Kurepa D, Perveen S, Lipener Y, Kakkilaya V. The use of less invasive surfactant administration (LISA) in the United States with review of the literature. J Perinatol. 2019;39:426–32.
doi: 10.1038/s41372-018-0302-9
Öncel MY, Erdeve Ö. A national survey on use of less invasive surfactant administration in Turkey. Turk J Pediatr. 2020;62:787–94.
doi: 10.24953/turkjped.2020.05.010
Klotz D, Porcaro U, Fleck T, Fuchs H. European perspective on less invasive surfactant administration-a survey. Eur J Pediatr. 2017;176:147–54.
doi: 10.1007/s00431-016-2812-9
Bhayat S, Kaur A, Premadeva I, Reynolds P, Gowda H. Survey of less invasive surfactant administration in England, slow adoption and variable practice. Acta Paediatr Int J Paediatr. 2020;109:505–10.
doi: 10.1111/apa.14995